RH-Δompdc treatment increased the expression of IL-12 and IFN-γ, which may inhibit tumor angiogenesis, activate APCs and induce infiltrating T cells in the TME, thus reversing tumor immunosuppression to suppress 4T1 breast tumor growth and lung metastasis, and even induce systemic anti-tumor immunity. This evidence concerns the gene IFNG and breast neoplasm.